Pharmafile Logo
Pharmafocus logo
Advanced Search
pfizer_logo

Pfizer raised 100 US drug prices 1 January

January 12, 2016
Manufacturing and Production, Sales and Marketing Allergan, Drug pricing, Lyrica, Pfizer, ibrance, tax inversion

Drugs giant Pfizer raised the prices of more than 100 of its drugs in the US on 1 January,  in …

News
mark_alles_celgene

Mark Alles is new chief executive of Celgene

January 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Mark Alles

Celgene president and chief operating officer Mike Alles has been promoted to the top job after an executive restructure at …

Appointment
DMD

The Pharmafocus debate: Can ultra-orphan drugs be made cheaper?

January 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, Duchenne Muscular Dystrophy, Translarne, access to medicines, ataluren, muscular dystrophy, rare disease, ultra orphan drugs, ultra-orphan drugs

The recent reimbursement wrangle between PTC Therapeutics and NICE, the UK healthcare watchdog, has once again raised difficult questions about …

Feature
Roche building

Roche snaps up Tensha Therapeutics for up to $535m

January 12, 2016
Manufacturing and Production, Research and Development Roche, Tensha Therapeutics

Roche has acquired Tensha Therapeutics, a privately-held company based in Cambridge, Massachusetts for up to $535 million.The deal that gives …

News
genomics

Genomics appoints Sekar Kathiresan as scientific advisory board chair

January 11, 2016
Sales and Marketing genomics

Genomics has appointed Dr Sekar Kathiresan as chair of the company’s newly-formed scientific advisory board as chair, with immediate effect. Dr …

Appointment
AbbVie logo

AbbVie tests new hepatitis C drug in Phase III trials

January 11, 2016
Research and Development AbbVie, clinical trials, hepatitis C, phase III

AbbVie has announced it has begun six global Phase III trials of its once-daily, ribavirin-free investigational hepatitis C virus regimen, …

News
az_palmer

Three appointments in AstraZeneca’s global media relations team

January 11, 2016
Medical Communications AstraZeneca

Neil Burrows has joined as head of global media relations, following Esra Erkal-Paler’s promotion to head of global external communications.Burrows …

Appointment

Shire and Baxalta reach $32 billion merger agreement

January 11, 2016
Manufacturing and Production, Sales and Marketing Baxalta, Shire, mergers, mergers and acquisitions

One of the industry’s longest-running M&A sagas has finally reached a conclusion, with Shire and Baxalta announcing a $32 billion …

News

AbbVie begins late stage trials of rheumatoid arthritis drug

January 11, 2016
Manufacturing and Production, Research and Development, Sales and Marketing ABT-494, AbbVie, F-star, JAK-1 inhibitor, rheumatoid arthritis

AbbVie has begun a large phase III clinical trial programme for its next-generation rheumatoid arthritis (RA) treatment ABT-494, which the …

News
Elias Zerhouni

Sanofi seals double oncology research deals

January 11, 2016
Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research

Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …

News
novartis_window

Novartis expands immuno-oncology programme

January 11, 2016
Research and Development, Sales and Marketing Cancer, Novartis, Surface Oncology, collaboration, immuno-oncology

Novartis has further bolstered its immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology, as it moves …

News
GSK logo

GSK explains decision to halt payments to doctors

January 8, 2016
Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …

News
Mylan building

Mylan announces Momenta collaboration to develop six biosimilars

January 8, 2016
Manufacturing and Production, Sales and Marketing Heather Bresch, Momenta, Mylan, biosimilars

Mylan has entered an exclusive global collaboration agreement with Momenta Pharmaceuticals, to develop, manufacture and commercialise six of Momenta’s biosimilar …

News
UK flag

Teva launches biosimilar fertility treatment in the UK

January 8, 2016
Manufacturing and Production, Sales and Marketing Ovaleap, Teva, biosimilar

Teva has launched its biosimilar version of Merck’s fertility treatment Gonal-f in the UK, potentially bringing a more affordable version …

News

PCI Pharma Services expands customer support portal

January 8, 2016
Business Services PCI Pharma Services

PCI Pharma Services has announced the expansion of its proprietary client services online portal, Webflow, into all PCI Clinical Services …

News
Press release
Neil Woodford

Investment group renews calls for GSK to split

January 8, 2016
Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …

News
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016
Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …

Feature
FDA sign

FDA review for Sanofi and Regeneron’s biologic arthritis drug

January 8, 2016
Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab

The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …

News
Roche building

Roche presents new data for advanced bladder cancer immunotherapy

January 8, 2016
Medical Communications, Research and Development Roche, atezolizumab, bladder cancer

Roche has announced updated results from a pivotal Phase II study, showing its investigational cancer immunotherapy atezolizumab extended median progression …

News
Novartis image

Novartis and Qualcomm to develop smart inhaler technology for COPD

January 8, 2016
Manufacturing and Production, Medical Communications COPD, Novartis, Qualcomm Life, breezhaler, digital inhaler, qualcomm

Novartis has enlisted Qualcomm life to help the pharma giant develop the ‘next generation’ of its Breezhaler device for patients …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026